COVID-19 Coagulopathy: Whom to Anticoagulate and How? What Agents to…

Rush University Medical Center

S. Jain

TCT 2024 Insights: BTK and BTA - How is Promise II and DVA Making an…

TCT 2024 Insights

A. Dua

Pharmacomechanical Venous Thrombectomy

Gerard O'Sullivan

VTE Prophylaxis After THA for Asian Population: Pharmacological Prop…

Arthroplasty Society in Asia

M. Mihara

VTE Prophylaxis After THA: Chinese Experience

Arthroplasty Society in Asia

H. Cai

VTE Prophylaxis After THA in the Asians: Messages from 2019 AP VTE C…

Arthroplasty Society in Asia

A. Tanavalee

Lymphovenous Anastomosis Using Supermicrosurgery Is an Effective Tre…

UChicago Breast and Lymphedema Symposium 2019

R. Garza

How do I Recognize and Treat the VEXAS Syndrome?

Cleveland Clinic Rheumatology

P. Grayson

Five Things Every Internist Should Know About Anticoagulants

McMaster University Department of Medicine

S. Mithoowani

Sharp Recanalization Techniques for Chronic DVT

Brooke Spencer

Cancer-Associated Thrombosis: Defining, Risk Assessment, and Prognos…

BMFcases

T. Bat, M. Carrier

Peripheral Vein Cannulation Using Ultrasound: Should You Choose the …

Venous Edge

W. Marston, H. Gajraj

A Tale of Two Treatments: Trials and Tribulations of Treating Heel W…

Transformative Endovascular Decisions Conference

J. Randolph

Acute DVT: When to and When Not to Intervene?

Venous Edge

S. Elias, C. Pena, C. Huff, R. Winokur, K. BROWN

Risk Factors and Medical Management of PAD

Jefferson Health

T. Galanis

Extended Anticoagulation for VTE

Jeffrey Weitz

Common Femoral Vein Endovenectomy with Endoluminal Iliofemoral Venou…

Anthony Comerota

Prevention and Treatment of Cancer-Associated Thrombosis: What Are t…

James Douketis

Medical Management of DVT

NY Endovascular Summit

J. Goldfinger

Cancer-Associated Thrombosis: Anticoagulant Dose and Duration Consid…

BMFcases

T. Bat, M. Carrier